Affinity Asset Advisors LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-29 7:56 pm Purchase | 2026-01-22 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Affinity Asset Advisors LLC | 1,051,054 5.700% | 44,837 (+4.46%) | Filing |
| 2025-11-13 5:21 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Affinity Asset Advisors LLC | 1,006,217 7.650% | 455,452 (+82.69%) | Filing |
| 2024-12-31 4:13 pm Purchase | 2024-12-23 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Affinity Asset Advisors LLC | 550,765 5.300% | 550,765 (New Position) | Filing |